| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/03/2007 | EP1737432A2 Orally disintegrating tablets and methods of manufacture |
| 01/03/2007 | EP1737430A1 Method of preparing low-crystallinity oltipraz or amorphous oltipraz |
| 01/03/2007 | EP1737429A1 Transdermal delivery of beneficial substances effected by a hostile biophysical environment |
| 01/03/2007 | EP1737414A2 Vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain |
| 01/03/2007 | EP1737412A2 Use of sulfated hyaluronic acid |
| 01/03/2007 | EP1737386A1 Methods of treatment with syk inhibitors |
| 01/03/2007 | EP1737297A2 Imidazole compounds |
| 01/03/2007 | EP1701726A4 Antimicrobial photodynamic therapy compound and method of use |
| 01/03/2007 | EP1673074B1 Liquid preparation containing tobramycin |
| 01/03/2007 | EP1660099A4 Intravascular delivery of non-viral nucleic acid |
| 01/03/2007 | EP1654253B1 Substituted 3-pyrrolidin-indole derivatives |
| 01/03/2007 | EP1641466B1 2-methylene-19-nor-20(s)-25-methyl-1alpha-hydroxycalciferol and its uses |
| 01/03/2007 | EP1633699B1 Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents |
| 01/03/2007 | EP1633394B1 Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds |
| 01/03/2007 | EP1613602B1 Alkylated iminodibenzyls as antioxidants |
| 01/03/2007 | EP1608360B1 Synergistic hepatoprotective composition and a method thereof |
| 01/03/2007 | EP1596851B1 The use of sodium 2-mercaptoethanesulfonate as antiviral agent |
| 01/03/2007 | EP1572685B1 Substituted benzodioxepins |
| 01/03/2007 | EP1569930B1 Indol derivatives and their use as 5-ht ligands |
| 01/03/2007 | EP1562925B1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 01/03/2007 | EP1562492B1 Apparatus for the detection and occlusion of blood vessels |
| 01/03/2007 | EP1558216A4 Cross-linked polymer matrices, and methods of making and using same |
| 01/03/2007 | EP1553938B1 Use of epothilone derivatives for the treatment of hyperparathyroidism |
| 01/03/2007 | EP1527176B1 Further novel forms of interfering rna molecules |
| 01/03/2007 | EP1509230B1 Gefitinib (iressa) for the treatment of cancer |
| 01/03/2007 | EP1485098B1 Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo¬1,5-b|pyridazine in nanoparticulate form |
| 01/03/2007 | EP1463487A4 Liposomal delivery of vitamin e based compounds |
| 01/03/2007 | EP1448771B1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof |
| 01/03/2007 | EP1448208B1 Composition based on diosgenin ester for topical use |
| 01/03/2007 | EP1448168B1 Pharmaceutical formulation comprising bicalutamide |
| 01/03/2007 | EP1439843A4 Tetracycline derivatives and methods of use thereof |
| 01/03/2007 | EP1436389B1 Thrombin-cleavable chimeric proteins |
| 01/03/2007 | EP1429753B1 Pharmaceutical composition comprising gamma-butyrobetaine |
| 01/03/2007 | EP1423381B1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 01/03/2007 | EP1411889B1 Cream for treatment of skin injured by the sun |
| 01/03/2007 | EP1401450B1 Use of a pyridazinone derivative for the treatment of congestive heart failure |
| 01/03/2007 | EP1390040B1 Pharmaceutical composition for use in hormone replacement therapy |
| 01/03/2007 | EP1389617B1 Heterocyclic compound and antitumor agent containing the same as active ingredient |
| 01/03/2007 | EP1385876B1 Gonococcal proteins and nucleic acids |
| 01/03/2007 | EP1383514B1 Use of a composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters |
| 01/03/2007 | EP1377315B1 Pharmaceutical compositions of rapmycins |
| 01/03/2007 | EP1363615B1 Preservation of body protein |
| 01/03/2007 | EP1355626B1 Veterinary dermatologic composition |
| 01/03/2007 | EP1347780B1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 01/03/2007 | EP1343459B1 Composition, in particular cosmetic, containing 7-hydroxy dhea and/or 7-keto dhea and at least one isoflavonoid |
| 01/03/2007 | EP1328319B1 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 01/03/2007 | EP1322176B1 Use of carnitine for enhancing training-induced bradycardia |
| 01/03/2007 | EP1304371B1 Cds1 knockout mice and cell lines established thereof |
| 01/03/2007 | EP1280798B1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 01/03/2007 | EP1278515B1 Pharmaceutical formulation comprising carrier beads coated with a layer of valaciclovir |
| 01/03/2007 | EP1267826B1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 01/03/2007 | EP1265907B1 Novel aryl fructose-1,6-bisphosphatase inhibitors |
| 01/03/2007 | EP1231914B1 Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 01/03/2007 | EP1223944B1 Thrombopoietin mimetics |
| 01/03/2007 | EP1221865B1 Food supplement for increasing lean mass and strength |
| 01/03/2007 | EP1221439B1 Tetrahydroquinoline derivatives |
| 01/03/2007 | EP1212071B1 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 01/03/2007 | EP1210116B1 Pharmaceutical combination for the treatment of viral infections containing a calcium channel blocker and a quinoline |
| 01/03/2007 | EP1202963B1 Spla2 inhibitors |
| 01/03/2007 | EP1192184B1 Surfactant protein c esters |
| 01/03/2007 | EP1162975B1 Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin |
| 01/03/2007 | EP1126839B1 Substituted phenethylsulfones and method of reducing tnf-alpha and pde-iv levels |
| 01/03/2007 | EP1104462B1 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 01/03/2007 | EP1093379B1 Use of inhibitors of protein kinase c epsilon to treat pain |
| 01/03/2007 | EP1082106B1 Effervescent tablet for the sublingual, buccal and gingival administration of fentanyl |
| 01/03/2007 | EP1071440B1 Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga |
| 01/03/2007 | EP1049470B1 Extended release tiagabine formulations with reduced side-effects |
| 01/03/2007 | EP1024794B1 Methods of treating capsules and dry, powdered pharmaceutical formulations |
| 01/03/2007 | EP1009385B2 Cholesterol level lowering composition |
| 01/03/2007 | EP0896626B1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
| 01/03/2007 | EP0863768B1 Covalent heparin-protein conjugates comprising an alpha-carbonyl amine bond and methods of obtaining them |
| 01/03/2007 | CN1890383A Hinge core mimetibodies, compositions, methods and uses |
| 01/03/2007 | CN1890359A Adhesion inhibition of micro organisms by non-ionic surfactants |
| 01/03/2007 | CN1890252A New class of gamma delta T cells activators and use thereof |
| 01/03/2007 | CN1890249A Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 01/03/2007 | CN1890248A Novel compounds |
| 01/03/2007 | CN1890242A 吡唑并和咪唑并－嘧啶衍生物 And imidazo pyrazolo - pyrimidine derivatives |
| 01/03/2007 | CN1890241A A2b adenosine receptor antagonists |
| 01/03/2007 | CN1890240A Diazabicyclononene derivatives and their use as renin inhibitors |
| 01/03/2007 | CN1890239A Azabicyclooctene and other tetrahydropyridine derivatives with a new side-chain |
| 01/03/2007 | CN1890238A Hydronopol derivatives as agonists on human ORL1 receptors |
| 01/03/2007 | CN1890236A Novel thiazole derivates |
| 01/03/2007 | CN1890235A Benzopyranone compounds, compositions thereof, and methods of treatment therewith |
| 01/03/2007 | CN1890234A Novel quinoline derivatives |
| 01/03/2007 | CN1890228A Alpha-amino acid derivatives and use thereof as medicines |
| 01/03/2007 | CN1890227A Benzoxazine derivatives and uses thereof |
| 01/03/2007 | CN1890226A Oxazole derivatives of tetracyclines |
| 01/03/2007 | CN1890225A Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors |
| 01/03/2007 | CN1890224A 6-substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose)polymerase inhibitors |
| 01/03/2007 | CN1890221A 1-N-phenyl-amino-1H-imidazole derivatives and pharmaceutical compositions containing them |
| 01/03/2007 | CN1890220A A crystalline of the salt form of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing the same |
| 01/03/2007 | CN1890219A Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (GLK) activators |
| 01/03/2007 | CN1890218A Tubulin inhibitors |
| 01/03/2007 | CN1890217A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B |
| 01/03/2007 | CN1890215A Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 01/03/2007 | CN1890214A Heterocyclic- or aryloxy, -thio or -amino substituted indoles-2-carboxylic acids or esters as pai-1 |
| 01/03/2007 | CN1890213A Process for the preparation of n-amino substituted heterocyclic compounds |
| 01/03/2007 | CN1890212A Methods of preparing compounds useful as protease inhibitors |
| 01/03/2007 | CN1890205A Remedy |
| 01/03/2007 | CN1889996A Combination of flupirtine and tramadol |